Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-03-02 @ 3:44 PM
Study NCT ID:
NCT02489318
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-22
First Post:
2015-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
Sponsor:
Aragon Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2015-07-01
First Submit QC Date:
None
Study First Post Date:
2015-07-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-06
Results First Submit QC Date:
None
Results First Post Date:
2022-01-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED